What’s Going On With Molson Coors Stock Today?
Molson Coors Beverage Company (NYSE: TAP) shares are trading higher after the company reported better-than-expected fourth-quarter EPS and sales results.
Why Chemomab Therapeutics Shares Are Trading Higher Today
Chemomab Therapeutics Ltd (NASDAQ: CMMB) shares are trading higher on Tuesday after the company announced FDA clearance of its Investigational New Drug Application to evaluate CM-101 in a Phase 2 trial in
Aileron Therapeutics Shelves Development On Chemoprotection Agent, Shares Fall
Aileron Therapeutics (NASDAQ:ALRN) announced that a review of initial data from its Phase 1b chemoprotection trial of ALRN-6924 in p53-mutated breast…
Corvus Pharma’s HIV Candidate Shows Potential To Prevent Virus Re-Emergence
Corvus Pharmaceuticals Inc (NASDAQ:CRVS) announced new data demonstrating the potential of CPI-818, an ITK inhibitor, to reduce the need for chronic…
12 Information Technology Stocks Moving In Tuesday’s Intraday Session
Gainers Mobilicom (NASDAQ:MOB) stock increased by 40.6% to $2.18 during Tuesday’s regular session. Trading volume for Mobilicom’s stock…
Photronics Shares Trade Lower After Sharing Cautious Q2 Outlook
Photronics, Inc (NASDAQ:PLAB) reported first-quarter revenue growth of 11% year-on-year to $211.1 million, beating the consensus of $201 million. IC…
What Home Depot Q4 Earnings Mean For Lowe’s, The Broader Economy
Home Depot Inc (NYSE: HD) shares are sliding on weak quarterly results, and one analyst sees the report as a sign that consumer spending is softening due to inflation.
Why This DocuSign Analyst Has Just Turned Bearish
Shares of DocuSign Inc (NASDAQ: DOCU) came under pressure last week, after the company announced plans to slash 10% of its workforce.
Why Are Apellis Pharmaceuticals Shares Trading Higher Today?
The FDA approved Apellis Pharmaceuticals Inc’s (NASDAQ:APLS) Syfovre (pegcetacoplan injection) for geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Syfovre…
Dana Drops As Q4 Earnings Hit By Incremental Costs; Forecasts Huge FY23 Bottom-Line Miss
Dana Inc (NYSE:DAN) reported fourth-quarter FY22 sales growth of 12.4% year-on-year to $2.56 billion, beating the consensus of $2.51 billion. Light…